Global Targeted Drugs for NSCLC Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Global Targeted Drugs for NSCLC Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Targeted Drugs for NSCLC Market Overview
1.1 Product Overview and Scope of Targeted Drugs for NSCLC
1.2 Classification of Targeted Drugs for NSCLC by Types
1.2.1 Global Targeted Drugs for NSCLC Revenue Comparison by Types (2019-2024)
1.2.2 Global Targeted Drugs for NSCLC Revenue Market Share by Types in 2018
1.2.3 Target EGFR
1.2.4 Target ALK
1.2.5 Target HER2
1.2.6 Target ROS1
1.2.7 Target BRAF
1.2.8 Target MEK
1.2.9 Target VEGFR2
1.2.10 Target VEGF
1.2.11 Target MET
1.3 Global Targeted Drugs for NSCLC Market by Application
1.3.1 Global Targeted Drugs for NSCLC Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Squamous Cell Carcinoma of NSCLC
1.3.3 Adenocarcinoma of NSCLC
1.3.4 Large Cell Carcinoma of NSCLC
1.4 Global Targeted Drugs for NSCLC Market by Regions
1.4.1 Global Targeted Drugs for NSCLC Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Targeted Drugs for NSCLC Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Targeted Drugs for NSCLC Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Targeted Drugs for NSCLC Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Targeted Drugs for NSCLC Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Targeted Drugs for NSCLC Status and Prospect (2014-2024)
1.5 Global Market Size of Targeted Drugs for NSCLC (2014-2024)
2 Manufacturers Profiles
2.1 Allergan
2.1.1 Business Overview
2.1.2 Targeted Drugs for NSCLC Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Allergan Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.2 Amgen
2.2.1 Business Overview
2.2.2 Targeted Drugs for NSCLC Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Amgen Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.3 ARIAD Pharmaceuticals (Takeda)
2.3.1 Business Overview
2.3.2 Targeted Drugs for NSCLC Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.4 Beacon Pharma Limited
2.4.1 Business Overview
2.4.2 Targeted Drugs for NSCLC Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Beacon Pharma Limited Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.5 BeiGene
2.5.1 Business Overview
2.5.2 Targeted Drugs for NSCLC Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 BeiGene Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.6 Biocon
2.6.1 Business Overview
2.6.2 Targeted Drugs for NSCLC Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Biocon Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.7 Boehringer-Ingelheim
2.7.1 Business Overview
2.7.2 Targeted Drugs for NSCLC Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Boehringer-Ingelheim Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.8 Celgene Corporation
2.8.1 Business Overview
2.8.2 Targeted Drugs for NSCLC Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Celgene Corporation Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.9 Drug International Limted
2.9.1 Business Overview
2.9.2 Targeted Drugs for NSCLC Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Drug International Limted Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.10 Fujifilm Kyowa Kirin Biologics
2.10.1 Business Overview
2.10.2 Targeted Drugs for NSCLC Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Fujifilm Kyowa Kirin Biologics Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.11 Genvio Pharma Limited
2.11.1 Business Overview
2.11.2 Targeted Drugs for NSCLC Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Genvio Pharma Limited Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.12 Hetero Drugs
2.12.1 Business Overview
2.12.2 Targeted Drugs for NSCLC Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Hetero Drugs Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.13 ImClone Systems ?(Eli Lilly)
2.13.1 Business Overview
2.13.2 Targeted Drugs for NSCLC Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 ImClone Systems ?(Eli Lilly) Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.14 Incepta Pharmaceuticals
2.14.1 Business Overview
2.14.2 Targeted Drugs for NSCLC Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Incepta Pharmaceuticals Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.15 Mylan
2.15.1 Business Overview
2.15.2 Targeted Drugs for NSCLC Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Mylan Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.16 Novartis
2.16.1 Business Overview
2.16.2 Targeted Drugs for NSCLC Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Novartis Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.17 Pfizer
2.17.1 Business Overview
2.17.2 Targeted Drugs for NSCLC Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Pfizer Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.18 Reliance Lifesciences
2.18.1 Business Overview
2.18.2 Targeted Drugs for NSCLC Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Reliance Lifesciences Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.19 Roche
2.19.1 Business Overview
2.19.2 Targeted Drugs for NSCLC Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Roche Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.20 AstraZeneca
2.20.1 Business Overview
2.20.2 Targeted Drugs for NSCLC Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 AstraZeneca Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.21 Cipla
2.21.1 Business Overview
2.2.2 Targeted Drugs for NSCLC Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Cipla Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.22 Teva
2.22.1 Business Overview
2.22.2 Targeted Drugs for NSCLC Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Teva Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.23 OSI Pharmaceuticals
2.23.1 Business Overview
2.23.2 Targeted Drugs for NSCLC Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 OSI Pharmaceuticals Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.24 Glenmark Pharmaceuticals
2.24.1 Business Overview
2.24.2 Targeted Drugs for NSCLC Type and Applications
2.24.2.1 Product A
2.24.2.2 Product B
2.24.3 Glenmark Pharmaceuticals Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
2.25 Natco Pharma
2.25.1 Business Overview
2.25.2 Targeted Drugs for NSCLC Type and Applications
2.25.2.1 Product A
2.25.2.2 Product B
2.25.3 Natco Pharma Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
3 Global Targeted Drugs for NSCLC Market Competition, by Players
3.1 Global Targeted Drugs for NSCLC Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Targeted Drugs for NSCLC Players Market Share
3.2.2 Top 10 Targeted Drugs for NSCLC Players Market Share
3.3 Market Competition Trend
4 Global Targeted Drugs for NSCLC Market Size by Regions
4.1 Global Targeted Drugs for NSCLC Revenue and Market Share by Regions
4.2 North America Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
4.3 Europe Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
4.5 South America Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
5 North America Targeted Drugs for NSCLC Revenue by Countries
5.1 North America Targeted Drugs for NSCLC Revenue by Countries (2014-2019)
5.2 USA Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
5.3 Canada Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
5.4 Mexico Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
6 Europe Targeted Drugs for NSCLC Revenue by Countries
6.1 Europe Targeted Drugs for NSCLC Revenue by Countries (2014-2019)
6.2 Germany Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
6.3 UK Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
6.4 France Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
6.5 Russia Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
6.6 Italy Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Targeted Drugs for NSCLC Revenue by Countries
7.1 Asia-Pacific Targeted Drugs for NSCLC Revenue by Countries (2014-2019)
7.2 China Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
7.3 Japan Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
7.4 Korea Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
7.5 India Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
8 South America Targeted Drugs for NSCLC Revenue by Countries
8.1 South America Targeted Drugs for NSCLC Revenue by Countries (2014-2019)
8.2 Brazil Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
8.3 Argentina Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
8.4 Colombia Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Targeted Drugs for NSCLC by Countries
9.1 Middle East and Africa Targeted Drugs for NSCLC Revenue by Countries (2014-2019)
9.2 Saudi Arabia Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
9.3 UAE Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
9.4 Egypt Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
9.5 Nigeria Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
9.6 South Africa Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
10 Global Targeted Drugs for NSCLC Market Segment by Type
10.1 Global Targeted Drugs for NSCLC Revenue and Market Share by Type (2014-2019)
10.2 Global Targeted Drugs for NSCLC Market Forecast by Type (2019-2024)
10.3 Target EGFR Revenue Growth Rate (2014-2024)
10.4 Target ALK Revenue Growth Rate (2014-2024)
10.5 Target HER2 Revenue Growth Rate (2014-2024)
10.6 Target ROS1 Revenue Growth Rate (2014-2024)
10.7 Target BRAF Revenue Growth Rate (2014-2024)
10.8 Target MEK Revenue Growth Rate (2014-2024)
10.9 Target VEGFR2 Revenue Growth Rate (2014-2024)
10.10 Target VEGF Revenue Growth Rate (2014-2024)
10.11 Target MET Revenue Growth Rate (2014-2024)
11 Global Targeted Drugs for NSCLC Market Segment by Application
11.1 Global Targeted Drugs for NSCLC Revenue Market Share by Application (2014-2019)
11.2 Targeted Drugs for NSCLC Market Forecast by Application (2019-2024)
11.3 Squamous Cell Carcinoma of NSCLC Revenue Growth (2014-2019)
11.4 Adenocarcinoma of NSCLC Revenue Growth (2014-2019)
11.5 Large Cell Carcinoma of NSCLC Revenue Growth (2014-2019)
12 Global Targeted Drugs for NSCLC Market Size Forecast (2019-2024)
12.1 Global Targeted Drugs for NSCLC Market Size Forecast (2019-2024)
12.2 Global Targeted Drugs for NSCLC Market Forecast by Regions (2019-2024)
12.3 North America Targeted Drugs for NSCLC Revenue Market Forecast (2019-2024)
12.4 Europe Targeted Drugs for NSCLC Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Targeted Drugs for NSCLC Revenue Market Forecast (2019-2024)
12.6 South America Targeted Drugs for NSCLC Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Targeted Drugs for NSCLC Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Targeted Drugs for NSCLC Picture
Table Product Specifications of Targeted Drugs for NSCLC
Table Global Targeted Drugs for NSCLC and Revenue (Million USD) Market Split by Product Type
Figure Global Targeted Drugs for NSCLC Revenue Market Share by Types in 2018
Figure Target EGFR Picture
Figure Target ALK Picture
Figure Target HER2 Picture
Figure Target ROS1 Picture
Figure Target BRAF Picture
Figure Target MEK Picture
Figure Target VEGFR2 Picture
Figure Target VEGF Picture
Figure Target MET Picture
Table Global Targeted Drugs for NSCLC Revenue (Million USD) by Application (2014-2024)
Figure Targeted Drugs for NSCLC Revenue Market Share by Applications in 2018
Figure Squamous Cell Carcinoma of NSCLC Picture
Figure Adenocarcinoma of NSCLC Picture
Figure Large Cell Carcinoma of NSCLC Picture
Table Global Market Targeted Drugs for NSCLC Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Targeted Drugs for NSCLC Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Targeted Drugs for NSCLC Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Targeted Drugs for NSCLC Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Targeted Drugs for NSCLC Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Targeted Drugs for NSCLC Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Targeted Drugs for NSCLC Revenue (Million USD) and Growth Rate (2014-2024)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Targeted Drugs for NSCLC Type and Applications
Table Allergan Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Targeted Drugs for NSCLC Type and Applications
Table Amgen Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table ARIAD Pharmaceuticals (Takeda) Basic Information, Manufacturing Base and Competitors
Table ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Type and Applications
Table ARIAD Pharmaceuticals (Takeda) Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Beacon Pharma Limited Basic Information, Manufacturing Base and Competitors
Table Beacon Pharma Limited Targeted Drugs for NSCLC Type and Applications
Table Beacon Pharma Limited Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table BeiGene Basic Information, Manufacturing Base and Competitors
Table BeiGene Targeted Drugs for NSCLC Type and Applications
Table BeiGene Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Biocon Basic Information, Manufacturing Base and Competitors
Table Biocon Targeted Drugs for NSCLC Type and Applications
Table Biocon Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Boehringer-Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer-Ingelheim Targeted Drugs for NSCLC Type and Applications
Table Boehringer-Ingelheim Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Celgene Corporation Basic Information, Manufacturing Base and Competitors
Table Celgene Corporation Targeted Drugs for NSCLC Type and Applications
Table Celgene Corporation Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Drug International Limted Basic Information, Manufacturing Base and Competitors
Table Drug International Limted Targeted Drugs for NSCLC Type and Applications
Table Drug International Limted Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Fujifilm Kyowa Kirin Biologics Basic Information, Manufacturing Base and Competitors
Table Fujifilm Kyowa Kirin Biologics Targeted Drugs for NSCLC Type and Applications
Table Fujifilm Kyowa Kirin Biologics Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Genvio Pharma Limited Basic Information, Manufacturing Base and Competitors
Table Genvio Pharma Limited Targeted Drugs for NSCLC Type and Applications
Table Genvio Pharma Limited Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Hetero Drugs Basic Information, Manufacturing Base and Competitors
Table Hetero Drugs Targeted Drugs for NSCLC Type and Applications
Table Hetero Drugs Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table ImClone Systems ?(Eli Lilly) Basic Information, Manufacturing Base and Competitors
Table ImClone Systems ?(Eli Lilly) Targeted Drugs for NSCLC Type and Applications
Table ImClone Systems ?(Eli Lilly) Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Incepta Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Incepta Pharmaceuticals Targeted Drugs for NSCLC Type and Applications
Table Incepta Pharmaceuticals Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Targeted Drugs for NSCLC Type and Applications
Table Mylan Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Targeted Drugs for NSCLC Type and Applications
Table Novartis Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Targeted Drugs for NSCLC Type and Applications
Table Pfizer Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Reliance Lifesciences Basic Information, Manufacturing Base and Competitors
Table Reliance Lifesciences Targeted Drugs for NSCLC Type and Applications
Table Reliance Lifesciences Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Targeted Drugs for NSCLC Type and Applications
Table Roche Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Targeted Drugs for NSCLC Type and Applications
Table AstraZeneca Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Cipla Basic Information, Manufacturing Base and Competitors
Table Cipla Targeted Drugs for NSCLC Type and Applications
Table Cipla Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Targeted Drugs for NSCLC Type and Applications
Table Teva Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table OSI Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table OSI Pharmaceuticals Targeted Drugs for NSCLC Type and Applications
Table OSI Pharmaceuticals Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Glenmark Pharmaceuticals Targeted Drugs for NSCLC Type and Applications
Table Glenmark Pharmaceuticals Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Natco Pharma Basic Information, Manufacturing Base and Competitors
Table Natco Pharma Targeted Drugs for NSCLC Type and Applications
Table Natco Pharma Targeted Drugs for NSCLC Revenue, Gross Margin and Market Share (2017-2018)
Table Global Targeted Drugs for NSCLC Revenue (Million USD) by Players (2014-2019)
Table Global Targeted Drugs for NSCLC Revenue Share by Players (2014-2019)
Figure Global Targeted Drugs for NSCLC Revenue Share by Players in 2017
Figure Global Targeted Drugs for NSCLC Revenue Share by Players in 2018
Figure Global Top 5 Players Targeted Drugs for NSCLC Revenue Market Share in 2018
Figure Global Top 10 Players Targeted Drugs for NSCLC Revenue Market Share in 2018
Figure Global Targeted Drugs for NSCLC Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Targeted Drugs for NSCLC Revenue (Million USD) by Regions (2014-2019)
Table Global Targeted Drugs for NSCLC Revenue Market Share by Regions (2014-2019)
Figure Global Targeted Drugs for NSCLC Revenue Market Share by Regions (2014-2019)
Figure Global Targeted Drugs for NSCLC Revenue Market Share by Regions in 2018
Figure North America Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure Europe Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure South America Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Table North America Targeted Drugs for NSCLC Revenue by Countries (2014-2019)
Table North America Targeted Drugs for NSCLC Revenue Market Share by Countries (2014-2019)
Figure North America Targeted Drugs for NSCLC Revenue Market Share by Countries (2014-2019)
Figure North America Targeted Drugs for NSCLC Revenue Market Share by Countries in 2018
Figure USA Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure Canada Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure Mexico Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Table Europe Targeted Drugs for NSCLC Revenue (Million USD) by Countries (2014-2019)
Figure Europe Targeted Drugs for NSCLC Revenue Market Share by Countries (2014-2019)
Figure Europe Targeted Drugs for NSCLC Revenue Market Share by Countries in 2018
Figure Germany Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure UK Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure France Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure Russia Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure Italy Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Targeted Drugs for NSCLC Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Targeted Drugs for NSCLC Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Targeted Drugs for NSCLC Revenue Market Share by Countries in 2018
Figure China Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure Japan Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure Korea Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure India Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Table South America Targeted Drugs for NSCLC Revenue by Countries (2014-2019)
Table South America Targeted Drugs for NSCLC Revenue Market Share by Countries (2014-2019)
Figure South America Targeted Drugs for NSCLC Revenue Market Share by Countries (2014-2019)
Figure South America Targeted Drugs for NSCLC Revenue Market Share by Countries in 2018
Figure Brazil Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure Argentina Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure Colombia Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Targeted Drugs for NSCLC Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Targeted Drugs for NSCLC Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Targeted Drugs for NSCLC Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Targeted Drugs for NSCLC Revenue Market Share by Countries in 2018
Figure Saudi Arabia Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure UAE Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure Egypt Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure Nigeria Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Figure South Africa Targeted Drugs for NSCLC Revenue and Growth Rate (2014-2019)
Table Global Targeted Drugs for NSCLC Revenue (Million USD) by Type (2014-2019)
Table Global Targeted Drugs for NSCLC Revenue Share by Type (2014-2019)
Figure Global Targeted Drugs for NSCLC Revenue Share by Type (2014-2019)
Figure Global Targeted Drugs for NSCLC Revenue Share by Type in 2018
Table Global Targeted Drugs for NSCLC Revenue Forecast by Type (2019-2024)
Figure Global Targeted Drugs for NSCLC Market Share Forecast by Type (2019-2024)
Figure Global Target EGFR Revenue Growth Rate (2014-2019)
Figure Global Target ALK Revenue Growth Rate (2014-2019)
Figure Global Target HER2 Revenue Growth Rate (2014-2019)
Figure Global Target ROS1 Revenue Growth Rate (2014-2019)
Figure Global Target BRAF Revenue Growth Rate (2014-2019)
Figure Global Target MEK Revenue Growth Rate (2014-2019)
Figure Global Target VEGFR2 Revenue Growth Rate (2014-2019)
Figure Global Target VEGF Revenue Growth Rate (2014-2019)
Figure Global Target MET Revenue Growth Rate (2014-2019)
Table Global Targeted Drugs for NSCLC Revenue by Application (2014-2019)
Table Global Targeted Drugs for NSCLC Revenue Share by Application (2014-2019)
Figure Global Targeted Drugs for NSCLC Revenue Share by Application (2014-2019)
Figure Global Targeted Drugs for NSCLC Revenue Share by Application in 2018
Table Global Targeted Drugs for NSCLC Revenue Forecast by Application (2019-2024)
Figure Global Targeted Drugs for NSCLC Market Share Forecast by Application (2019-2024)
Figure Global Squamous Cell Carcinoma of NSCLC Revenue Growth Rate (2014-2019)
Figure Global Adenocarcinoma of NSCLC Revenue Growth Rate (2014-2019)
Figure Global Large Cell Carcinoma of NSCLC Revenue Growth Rate (2014-2019)
Figure Global Targeted Drugs for NSCLC Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Targeted Drugs for NSCLC Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Targeted Drugs for NSCLC Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Targeted Drugs for NSCLC Revenue Market Forecast (2019-2024)
Figure Europe Targeted Drugs for NSCLC Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Targeted Drugs for NSCLC Revenue Market Forecast (2019-2024)
Figure South America Targeted Drugs for NSCLC Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Targeted Drugs for NSCLC Revenue Market Forecast (2019-2024)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs